NVIDIA BioNeMo

NVIDIA BioNeMo is a generative AI platform designed to accelerate drug discovery by providing a framework for training, fine-tuning, and deploying large language models (LLMs) for biology. It supports various modalities including small molecules, proteins, and DNA/RNA sequences, enabling researchers to predict molecular structures and properties with unprecedented speed. The platform is part of the NVIDIA Clara suite and offers cloud-based APIs as well as local deployment options through NVIDIA DGX systems. By leveraging high-performance computing, BioNeMo helps pharmaceutical companies and biotechs reduce the time and cost associated with early-stage drug development. It integrates state-of-the-art models such as ESM for protein structure prediction and MegaMolBART for chemistry. Major industry players utilize the platform to scale their digital biology workflows and identify novel therapeutic candidates. BioNeMo represents a significant shift toward AI-native drug discovery, bridging the gap between computer science and wet-lab research.